Covidh Technologies Ltd to acquire iSERA Biological Pvt Ltd

Covidh Technologies Limited ("the Company") has exceuted a non-binding Letter of Intent ("LOI") dated February 23, 2026 with iSERA Biological Private Limited ("iSERA"), setting out the broad terms and conditions for the proposed acquisition of 100% equity shareholding of iSERA by the Company.

The proposed acquisition is subject to execution of definitive agreements, completion of satisfactory due diligence, receipt of necessary regulatory, statutory and shareholders' approvals, and fulfilment of agreed conditions precedent. Upon completion of the proposed transaction, iSERA Biological Private Limited shall become a wholly owned subsidiary of the Company.

The non-binding Letter of Intent records the mutual understanding between the parties regarding the proposed transaction and is non-binding in nature except for customary provisions relating to confidentiality, exclusivity, governing law, and costs.

Shares of Covidh Technologies Limited was last trading in BSE at Rs. 35.07 as compared to the previous close of Rs. 34.39. The total number of shares traded during the day was 1 in over 1 trades.

The stock hit an intraday high of Rs. 35.07 and intraday low of 35.07. The net turnover during the day was Rs. 35.00.

Source : Equity Bulls

Keywords

CovidhTechnologies INE899M01020 LOI Acquisition iSERABiological